No photo of Marco Rastrelli

View Scopus Profile

Marco Rastrelli

20002019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Rastrelli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 44 Article
  • 2 Conference contribution
  • 2 Review article

Aggressive merkel cell carcinoma after janus kinase inhibitor ruxolitinib for polycythemia vera

Rastrelli, M., Ferrazzi, B., Tropea, S., Costa, A., Finotto, S., Marino, D., Campana, L., Del Fiore, P., Rossi, C. R. & Alaibac, M., Jan 1 2019, In : In Vivo. 33, 5, p. 1667-1669 3 p.

Research output: Contribution to journal › Article

Open Access

    • Management of other recurrent retroperitoneal sarcomas

    Rastrelli, M., Tropea, S. & Rossi, C. R., Jan 1 2019, In : Updates in Surgery. p. 109-119 11 p.

    Research output: Contribution to journal › Article

    miRNA deregulation targets specific pathways in leiomyosarcoma development: an in silico analysis

    Benna, C., Rajendran, S., Rastrelli, M. & Mocellin, S., May 14 2019, In : Journal of Translational Medicine. 17, 1, p. 1-8 8 p., 153.

    Research output: Contribution to journal › Article

    • Myoepithelioma of the soft tissue: A systematic review of clinical reports

    Rastrelli, M., Del Fiore, P., Damiani, G. B., Mocellin, S., Tropea, S., Spina, R., Costa, A., Cavallin, F. & Rossi, C. R., Sep 2019, In : European Journal of Surgical Oncology. 45, 9, p. 1520-1526 7 p.

    Research output: Contribution to journal › Review article

    • NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

    Bonvalot, S., Rutkowski, P. L., Thariat, J., Carrère, S., Ducassou, A., Sunyach, M. P., Agoston, P., Hong, A., Mervoyer, A., Rastrelli, M., Moreno, V., Li, R. K., Tiangco, B., Herraez, A. C., Gronchi, A., Mangel, L., Sy-Ortin, T., Hohenberger, P., de Baère, T., Le Cesne, A. & 22 others, Helfre, S., Saada-Bouzid, E., Borkowska, A., Anghel, R., Co, A., Gebhart, M., Kantor, G., Montero, A., Loong, H. H., Vergés, R., Lapeire, L., Dema, S., Kacso, G., Austen, L., Moureau-Zabotto, L., Servois, V., Wardelmann, E., Terrier, P., Lazar, A. J., Bovée, J. V. M. G., Le Péchoux, C. & Papai, Z., Aug 2019, In : The Lancet Oncology. 20, 8, p. 1148-1159 12 p.

    Research output: Contribution to journal › Article